Siga Technologies INC Payments to Acquire Short-term Investments
Siga Technologies INC (SIGA) reported Payments to Acquire Short-term Investments of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2014-03-10
- Siga Technologies INC payments to acquire short-term investments for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- Siga Technologies INC payments to acquire short-term investments for the quarter ending 2012-09-30 was $0.00.
- Siga Technologies INC payments to acquire short-term investments for the quarter ending 2012-06-30 was $0.00, a 100.00% decline year-over-year.
- Siga Technologies INC payments to acquire short-term investments for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- Siga Technologies INC payments to acquire short-term investments for fiscal 2013 was $0.00.
- Siga Technologies INC payments to acquire short-term investments for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- Siga Technologies INC payments to acquire short-term investments for fiscal 2011 was $25.00M, a 39.36% decline from fiscal 2010.
- Siga Technologies INC payments to acquire short-term investments for fiscal 2010 was $41.24M, a 724.83% increase from fiscal 2009.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-10 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $0.00 derived: sum of 2 quarters · filed 2014-03-10 | $0.00 derived: sum of 3 quarters · filed 2014-03-10 | $0.00 10-K · filed 2014-03-10 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $0.00 derived: sum of 2 quarters · filed 2012-11-05 | $0.00 10-Q · filed 2012-11-05 | $11.79K derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $0.00 10-Q · filed 2012-08-06 | $11.79K derived: sum of 3 quarters · filed 2014-03-10 | $11.79K derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-07 | $11.79K derived: sum of 2 quarters · filed 2014-03-10 | $11.79K derived: sum of 3 quarters · filed 2014-03-10 | $10.01M derived: sum of 4 quarters · filed 2014-03-10 |
| 2011-12-31 | $11.79K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $11.79K derived: sum of 2 quarters · filed 2014-03-10 | $10.01M derived: sum of 3 quarters · filed 2014-03-10 | $25.00M 10-K · filed 2014-03-10 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $10.00M derived: sum of 2 quarters · filed 2012-11-05 | $24.99M 10-Q · filed 2012-11-05 | $39.99M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-06-30 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $24.99M 10-Q · filed 2012-08-06 | $39.99M derived: sum of 3 quarters · filed 2013-05-15 | |
| 2011-03-31 | $14.99M 10-Q · filed 2012-05-07 | $29.99M derived: sum of 2 quarters · filed 2013-05-15 | ||
| 2010-12-31 | $15.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-05-15 | $41.24M 10-K/A · filed 2013-05-15 | ||
| 2010-09-30 | $26.24M 10-Q · filed 2011-11-08 | |||
| 2009-12-31 | $5.00M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |